Emily P. Harrington, B.Sc.
Affiliations: | Pediatric | University of California, San Francisco, San Francisco, CA |
Google:
"Emily Harrington"Mean distance: 18.3 (cluster 11)
Parents
Sign in to add mentorDavid H. Rowitch | grad student | 2003-2012 | UCSF | |
(Manipulating developmental mechanisms to promote remyelination.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Harrington EP, Bergles DE, Calabresi PA. (2019) Immune cell modulation of oligodendrocyte lineage cells. Neuroscience Letters. 134601 |
Fancy SP, Harrington EP, Baranzini SE, et al. (2014) Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer. Nature Neuroscience. 17: 506-12 |
Fancy SPJ, Harrington EP, Baranzini SE, et al. (2014) Erratum: Corrigendum: Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer Nature Neuroscience. 17: 1841-1841 |
Meijer DH, Kane MF, Mehta S, et al. (2012) Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nature Reviews. Neuroscience. 13: 819-31 |
Fancy SP, Harrington EP, Yuen TJ, et al. (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nature Neuroscience. 14: 1009-16 |
Mehta S, Huillard E, Kesari S, et al. (2011) The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell. 19: 359-71 |
Harrington EP, Zhao C, Fancy SP, et al. (2010) Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Annals of Neurology. 68: 703-16 |
Fancy SP, Kotter MR, Harrington EP, et al. (2010) Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Experimental Neurology. 225: 18-23 |